To evaluate the efficacy of Phenazopyridine with Nitrofurantoin in patients with Urinary tract infectio
Phase 3
- Conditions
- Health Condition 1: N390- Urinary tract infection, site notspecified
- Registration Number
- CTRI/2024/06/068294
- Lead Sponsor
- ANJU JOSHUA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. patients with clinical symptoms or laboratory-documented urinary tract infection
2. patient willing to give informed consent
Exclusion Criteria
1. patients who have taken antibiotics in the last month
2. patients with congenital urinary tract abnormalities
3. patients with severe liver/renal impairment ( GFR <60 ml/min)
4. lactating women, pregnant women in third trimester
5. patients taking any medicine with clinically significant CYP induction or inhibition of nitrofurantoin or phenazopyridine
6. patients with a history of allergies to nitrofurantoin, phenazopyridine , paracetamol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method